Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Amneal Pharmaceuticals Inc (NY: AMRX ) 5.870 UNCHANGED Last Price Updated: 7:00 PM EST, Dec 26, 2023 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 0 Open 5.870 Bid (Size) 5.710 (1) Ask (Size) 6.000 (1) Prev. Close 5.870 Today's Range 5.870 - 5.870 52wk Range 1.720 - 5.870 Shares Outstanding 1,000 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Amneal Announces U.S. FDA Approval of Over-the-Counter Naloxone Hydrochloride Nasal Spray for Emergency Treatment of an Opioid Overdose April 24, 2024 From Amneal Pharmaceuticals, Inc. Via Business Wire Amneal Launches PEMRYDI RTU®, the First Ready-to-Use Version of Important Oncology Injectable Medicine April 16, 2024 From Amneal Pharmaceuticals, Inc. Via Business Wire Performance YTD N/A N/A 1 Month N/A N/A 3 Month N/A N/A 6 Month +55.70% +55.70% 1 Year +222.53% +222.53% More News Read More Amneal to Report First Quarter 2024 Results on May 3, 2024 April 10, 2024 From Amneal Pharmaceuticals, Inc. Via Business Wire Amneal to Ring the Nasdaq Closing Bell on April 2, 2024 March 28, 2024 From Amneal Pharmaceuticals, Inc. Via Business Wire Amneal Pharmaceuticals: Q4 Earnings Insights March 01, 2024 Via Benzinga Earnings Outlook For Amneal Pharmaceuticals February 29, 2024 Via Benzinga Amneal Receives U.S. FDA Approval for Ciprofloxacin and Dexamethasone Otic Suspension March 25, 2024 From Amneal Pharmaceuticals, Inc. Via Business Wire Why Is Generic Drug-Focused Amneal Pharmaceuticals Stock Trading Lower Friday? March 01, 2024 Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday March 01, 2024 Via InvestorPlace Earnings Scheduled For March 1, 2024 March 01, 2024 Via Benzinga Amneal Reports Fourth Quarter and Full Year 2023 Financial Results March 01, 2024 From Amneal Pharmaceuticals, Inc. Via Business Wire Amneal Enters into Exclusive European Licensing Agreement with Zambon Biotech for IPX203 February 27, 2024 From Amneal Pharmaceuticals, Inc. Via Business Wire 6 reasons to buy Teva Pharmaceuticals stock sooner than later February 26, 2024 Via MarketBeat Topics Lawsuit Exposures Financial Legal Amneal to Participate at Upcoming Investor Conference February 13, 2024 From Amneal Pharmaceuticals, Inc. Via Business Wire Amneal to Report Fourth Quarter and Full Year 2023 Results on March 1, 2024 January 31, 2024 From Amneal Pharmaceuticals, Inc. Via Business Wire Amneal Launches Complex Generic Fluorometholone Ophthalmic Suspension January 10, 2024 From Amneal Pharmaceuticals, Inc. Via Business Wire Amneal Launched Record Number of 39 New Retail and Injectable Products in 2023, Including 13 in Q4 2023 January 04, 2024 From Amneal Pharmaceuticals, Inc. Via Business Wire Amneal to Participate at the 42nd Annual J.P. Morgan Healthcare Conference December 21, 2023 From Amneal Pharmaceuticals, Inc. Via Business Wire Amneal Announces Move to Nasdaq December 15, 2023 From Amneal Pharmaceuticals, Inc. Via Business Wire Amneal and BIAL Announce U.S. Licensing Agreement for ONGENTYS® (opicapone) December 07, 2023 From Amneal Pharmaceuticals, Inc. Via Business Wire Amneal Expands Portfolio with Addition of Icosapent Ethyl Acid Soft Gel Capsules December 01, 2023 From Amneal Pharmaceuticals, Inc. Via Business Wire Amneal Reports Third Quarter 2023 Financial Results November 07, 2023 From Amneal Pharmaceuticals, Inc. Via Business Wire Amneal to Participate at Upcoming Investor Conferences November 03, 2023 From Amneal Pharmaceuticals, Inc. Via Business Wire Why Asbury Automotive Group Shares Are Trading Lower By Over 6%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session October 24, 2023 Via Benzinga General Electric, Verizon, Cleveland-Cliffs And Other Big Stocks Moving Higher On Tuesday October 24, 2023 Via Benzinga Topics Stocks Exposures US Equities Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.